What are the Historical Developments and Current Growth Metrics of the Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
The benign prostatic hyperplasia bph treatment devices and equipment market has seen considerable growth due to a variety of factors.
• The market for benign prostatic hyperplasia (BPH) treatment devices and equipment has demonstrated robust growth in recent times. The market value, which stood at $1.29 billion in 2024, is projected to increase to $1.38 billion by 2025, indicating a compound annual growth rate (CAGR) of 7.2%.
The significant growth witnessed in the historical period can be attributed to factors such as an aging population, heightened awareness and diagnosis, improved healthcare accessibility, and personalized treatment options.
What Does Future Hold for The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
The benign prostatic hyperplasia bph treatment devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• Growth of the benign prostatic hyperplasia (BPH) treatment devices and equipment market is predicted to be robust in the upcoming years, expanding to a size of $1.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%.
The surge expected during this forecast period is linked to factors such as minimally invasive methods, expansion in emerging markets, regulatory assistance, and value-based healthcare. Key trends projected for this period encompass non-surgical and office-based procedures, use of laser and radiofrequency technologies, telehealth and distant consultations, and increased patient education and involvement.
What Are The Essential Drivers Behind The Growth Of The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
The anticipated growth of the benign prostatic hyperplasia market can be attributed to the escalating number of prostate cancer cases. Prostate cancer originates in the prostate gland, a small gland shaped like a walnut located under the bladder in males. This resurgence in prostate cancer cases entails an increasing number of older males turning to medical professionals for prostate-related concerns. This scenario brings to the forefront the diagnosis and management of benign prostatic hyperplasia. For instance, the American Society of Clinical Oncology (ASCO), a prominent organization based in the US that delivers patient information on the cancer.net website reported in February 2023 that an estimated 288,300 males in the United States suffered from prostate cancer in the said year, while there were 268,490 fresh cases and 34,500 fatalities as a result of prostate cancer in 2022. Consequently, the rise in prostate cancer cases is fueling the expansion of the benign prostatic hyperplasia market.
What Is The Segmentation Of The Global Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
Pre-Book The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Landscape?
Leading businesses in the benign prostatic hyperplasia market are concentrating on the production of novel products, such as the UroLift 2 System and the UroLift ATC advanced tissue control system. These tools were introduced to treat lower urinary tract symptoms arising from benign prostatic hyperplasia (BPH). For example, in May 2022, Teleflex Incorporated, an American medical device corporation, introduced the UroLift 2 System and UroLift ATC. The UroLift 2 System is a designed delivery system that can reach the prostatic urethra to permanently install UroLift implants within the prostate lobes. On the other hand, the UroLift ATC advanced tissue control system is a non-invasive procedure to manage symptoms of an enlarged prostate by lifting and holding the swollen prostate tissue so it doesn't obstruct the urethra. This is a groundbreaking strategy for the treatment of benign prostatic hyperplasia (BPH).
Who Are the Key Players In The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include:
• Karl Storz
• Lumenis Ltd.
• Olympus Corporation
• Urologix LLC
• Boston scientific Inc.
• Endo International plc
• NeoTract Inc.
• OmniGuide Inc.
• Medifocus Inc.
• ProArc Medical Ltd.
• Teleflex Incorporated
• Medtronic plc
• Urotech Devices
• Prostalund Operations AB
• Baxter International
• NxThera Inc.
• Richard Wolf GmbH
• Coloplast A/S
• Siemens Healthineers
• Quest Pharmatech
• Protox Therapeutics
• IntelGenx Technologies Corp
• Astellas Pharma Inc.
• Ipsen S.A.
• Biolitec AG
• BVM Medical
• Convergent Laser Technologies
• Cook Medical
• GreenLight Technologies
• Merit Medical Systems
• Pnn Medical A/S
• PROCEPT BioRobotics
• Prosenex
• ProSolv CardioVascular Inc.
• Quanta System
• Rocamed SAM
• RZ Medizintechnik GmbH
• SRS Medical Systems
• UroShape LLC
• Vertebron Inc.
What Are The Regional Insights Into The Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
